glp-1 pdb PDB-101: Molecule of the Month: Receptor Agonists RCSB PDB - 3IOL: Crystal

2025 Comparative real-world cohort analysis reports lower diagnosis rates of vulvovaginal candidiasis/vaginitis phenotypes with semaglutide vs SGLT2 inhibitors

After you submit your medical info, a licensed provider reviews it remotely to decide whether you qualify for GLP-1 treatment

The Type 2 Diabetes Mellitus segment is expected to remain the largest application area for glucagon like peptide 1 analogs, representing 53.1% of the market in 2026

Researchers found that women who received a GLP-1 receptor agonist prescription before pregnancy were less likely to develop hypertensive disorders of pregnancy (19.9% vs

If you experience severe, persistent nausea or vomiting that prevents adequate fluid or food intake, contact your provider

Twarog C, Fattah S, Heade J, Maher S, Fattal E, Brayden DJ